Axsome Therapeutics, Inc. ($0.0001 par value per share) SALES AGREEMENTSales Agreement • March 1st, 2022 • Axsome Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 1st, 2022 Company Industry JurisdictionAxsome Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Securities LLC (the “Agent”), as follows: